ストックスクリーナーアプリを入手
18.06
6.74%
1.14
アフターアワーズ：
18.06
前日終値:
$16.92
開ける：
$17.3
24時間の取引高:
1.09M
Relative Volume:
2.14
時価総額：
$1.36B
収益：
$62.71M
当期純損益:
$-112.51M
株価収益率:
-11.96
EPS:
-1.51
ネットキャッシュフロー:
$-96.01M
1週間 パフォーマンス:
+6.61%
1か月 パフォーマンス:
+18.89%
6か月 パフォーマンス:
+91.31%
1年 パフォーマンス:
+40.65%
1日の値動き範囲:
$17.27
$18.35
1週間の範囲:
$16.20
$18.35
52週間の値動き範囲:
$9.03
$18.35
Zymeworks Inc. Stock (ZYME) Company Profile
名前
Zymeworks Inc.
セクター
電話
604-678-1388
住所
1385 West 8th Avenue, Suite 540, Vancouver, BC
ZYME を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ZYME
Zymeworks Inc.
|
18.06 | 1.28B | 62.71M | -112.51M | -96.01M | -1.51 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Zymeworks Inc. Stock (ZYME) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-20 | 開始されました | TD Cowen | Buy |
| 2024-12-16 | アップグレード | JP Morgan | Neutral → Overweight |
| 2024-11-07 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2024-11-01 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2023-03-21 | 再開されました | Wells Fargo | Overweight |
| 2023-01-04 | 繰り返されました | H.C. Wainwright | Neutral |
| 2022-12-20 | アップグレード | Jefferies | Hold → Buy |
| 2022-11-01 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2022-10-21 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2022-10-04 | 再開されました | Wells Fargo | Overweight |
| 2022-05-05 | アップグレード | Guggenheim | Neutral → Buy |
| 2022-03-15 | 開始されました | Evercore ISI | Outperform |
| 2021-12-10 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2021-11-17 | 再開されました | Guggenheim | Neutral |
| 2021-10-07 | 開始されました | Jefferies | Hold |
| 2021-03-31 | 開始されました | Credit Suisse | Outperform |
| 2021-02-25 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2021-02-08 | 再開されました | H.C. Wainwright | Buy |
| 2021-01-25 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-09-29 | 再開されました | JP Morgan | Neutral |
| 2020-08-06 | 開始されました | SVB Leerink | Outperform |
| 2020-01-10 | 開始されました | Wolfe Research | Outperform |
| 2019-12-09 | 開始されました | JP Morgan | Neutral |
| 2019-11-25 | 開始されました | H.C. Wainwright | Buy |
| 2019-11-20 | 開始されました | Guggenheim | Buy |
| 2019-09-30 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2019-08-30 | 開始されました | Stifel | Buy |
| 2019-07-18 | 開始されました | Deutsche Bank | Buy |
| 2018-05-11 | アップグレード | Barclays | Underweight → Equal Weight |
| 2018-03-19 | 開始されました | Raymond James | Outperform |
すべてを表示
Zymeworks Inc. (ZYME) 最新ニュース
Zymeworks stock hits 52-week high at 17.71 USD - Investing.com India
Zymeworks (ZYME) Coverage Initiated by B. Riley Securities with 'Buy' Rating | ZYME Stock News - GuruFocus
What technical models suggest about Zymeworks Inc.’s comebackPortfolio Performance Report & Daily Volume Surge Signals - newser.com
Zymeworks appoints Adam Schayowitz as acting chief development officer By Investing.com - Investing.com Nigeria
Will Zymeworks Inc. stock outperform growth indexes2025 Investor Takeaways & Daily Technical Stock Forecast Reports - newser.com
Zymeworks Appoints New Acting Chief Development Officer to Boost Therapeutic Advancements - TipRanks
Zymeworks appoints Adam Schayowitz as acting chief development officer - Investing.com India
Zymeworks Inc. Appoints Adam Schayowitz, Ph.D., MBA as Acting Chief Development Officer - Quiver Quantitative
Zymeworks Appoints Dr. Adam Schayowitz as Acting Chief Development Officer - Stock Titan
Q1 Earnings Forecast for Zymeworks Issued By Lifesci Capital - MarketBeat
How to forecast Zymeworks Inc. trends using time series2025 Dividend Review & Community Consensus Trade Alerts - newser.com
Is Zymeworks Inc a good long term investmentShort-Term Trading Alerts & Small Capital Trading Plans - earlytimes.in
Is Zymeworks Inc. stock entering bullish territoryPortfolio Risk Report & Free Fast Gain Swing Trade Alerts - newser.com
Why analysts maintain buy rating on Zymeworks Inc. (ZA8) stockJuly 2025 Patterns & Precise Swing Trade Entry Alerts - newser.com
Market reaction to Zymeworks Inc.’s recent news2025 Dividend Review & Technical Buy Zone Confirmation - newser.com
Key resistance and support levels for Zymeworks Inc.Quarterly Portfolio Review & Reliable Entry Point Alerts - newser.com
Zymeworks (ZYME): Assessing Valuation Following Recent Momentum in Biopharma - Sahm
Will Zymeworks Inc. stock outperform tech sector in 2025July 2025 Analyst Calls & Scalable Portfolio Growth Ideas - newser.com
Will Zymeworks Inc. stock recover faster than peersQuarterly Profit Summary & Daily Volume Surge Signals - newser.com
How Zymeworks Inc. (ZA8) stock stacks up against competitorsJuly 2025 Fed Impact & Fast Gain Swing Trade Alerts - newser.com
Zymeworks Inc Stock Analysis and ForecastMACD Histogram Signals & Get Tomorrow’s Winners Today With AI - earlytimes.in
Platinum Investment Management Ltd. Decreases Stake in Zymeworks Inc. $ZYME - MarketBeat
What indicators show strength in Zymeworks Inc.Trade Entry Summary & Weekly Watchlist of Top Performers - newser.com
Voya Investment Management LLC Sells 43,861 Shares of Zymeworks Inc. $ZYME - MarketBeat
What drives Zymeworks Inc stock priceStock Valuation Metrics & Exceptional Capital Investment - earlytimes.in
What analysts say about Zymeworks Inc stockTrading Psychology Tips & Rapid Portfolio Investment - earlytimes.in
Published on: 2025-09-30 00:00:12 - newser.com
Published on: 2025-09-29 03:57:31 - newser.com
Zymeworks Inc. (NYSE:ZYME) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Zymeworks Inc. (ZYME) 財務データ
収益
当期純利益
現金流量
EPS
Zymeworks Inc. (ZYME) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| EcoR1 Capital, LLC | Director |
May 19 '25 |
Buy |
11.78 |
5,919 |
69,738 |
17,883,908 |
| EcoR1 Capital, LLC | Director |
Apr 16 '25 |
Buy |
11.16 |
73,953 |
825,589 |
17,773,727 |
| EcoR1 Capital, LLC | Director |
Apr 17 '25 |
Buy |
11.52 |
54,760 |
630,819 |
17,828,487 |
| EcoR1 Capital, LLC | Director |
Apr 04 '25 |
Buy |
11.17 |
196,438 |
2,193,800 |
17,699,774 |
| EcoR1 Capital, LLC | Director |
Apr 03 '25 |
Buy |
11.84 |
120,770 |
1,430,170 |
17,503,336 |
| EcoR1 Capital, LLC | Director |
Apr 02 '25 |
Buy |
11.85 |
74,360 |
881,017 |
17,382,566 |
| EcoR1 Capital, LLC | Director |
Apr 01 '25 |
Buy |
11.60 |
48,658 |
564,647 |
17,308,206 |
| EcoR1 Capital, LLC | Director |
Mar 31 '25 |
Buy |
11.75 |
4,397 |
51,658 |
17,259,548 |
| EcoR1 Capital, LLC | Director |
Mar 25 '25 |
Buy |
12.91 |
53,501 |
690,452 |
17,211,303 |
| EcoR1 Capital, LLC | Director |
Mar 26 '25 |
Buy |
12.24 |
43,848 |
536,857 |
17,255,151 |
5.74%
大文字化:
|
ボリューム (24 時間):